Thursday, December 20, 2007 12:36:58 PM
There is SOME bad news in the PR.
This makes it very unlikely that antiThrombin can compete with Ampligen as a miracle cure for everything
This makes it very unlikely that antiThrombin can compete with Ampligen as a miracle cure for everything
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
